PANCREATIC S2001
Study #S2001Randomized Phase II Clinical Trial of Olaparib + Pebrolizumab vs. Olaparib Alone as Maintenance Therapy in Metastatic Pancreatic Cancer Patients with Germline BRCA1 or BRCA2 Mutations
Back To Clinical Trials NCI Database Entry